the aid library

Filter

5000

National Guidelines for Cholera Control

Dept. of Health, Republic of South Africa (2014) C1

The document outlines comprehensive guidelines for managing cholera outbreaks in South Africa, focusing on prevention, diagnosis, treatment, and public health measures. It emphasizes the importance of rehydration therapy, sanitation, clean water access, and community involvement to control the sprea ... more

Rwanda: GYNECOLOGY AND OBSTETRICS CLINICAL PROTOCOLS & TREATMENT GUIDELINES

Ministry of Health, Rwanda (2012) C2

The guidelines presented in this document are designed to provide a useful resource for healthcare professionals involved in clinical case management. They were developed taking into consideration services provided at different levels within the health system and resources available. These guideline ... more

Interim National Guidelines for Monkeypox Outbreak Response

Federal Ministry of Health - Nigeria Centre for Disease Contro (2017) C2

This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.

Uganda: Quality Improvement Manual for TB Care Services

Ministry of Health, Republic of Uganda (2017) C2

National Tuberculosis and Leprosy Control Program

COTS (Cholera Outbreak Training and Shigellosis) Program Health Promotion Worker Pocket Card
recommended

COTS Program Cholera Outbreak Training and Shigellosis (2011) CC

The COTS Cholera Outbreak Training and Shigellosis Program Pocket Card provides essential guidelines for health promotion workers to prevent and manage cholera and shigellosis outbreaks. It emphasizes proper sanitation, hygiene practices, safe water handling, and food safety as the primary methods f ... more

Plan national de réponse à l’épidémie de choléra au Cameroun. Août–Octobre 2018

République du Cameroun, Ministère de la santé publique (2018) CC

The document presents Cameroon's National Response Plan for the 2018 cholera outbreak, covering August to October 2018. It highlights the epidemiological situation, with outbreaks reported in the North and Central regions and a total of 109 suspected cases and 9 deaths by July 2018. The plan outline ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID ... -19 The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Mesures de Base contre les infections associées aux soins

Organisation Mondiale de la Santé OMS (2007)

Management of Waste from Injection Activities at District Level
recommended

World Health Organization (2006) C_WHO

Guidelines for District Health Managers

Prevención de las infecciones nosocomiales

Organización Mundial de la Salud (2002)

Facts on Ebola Hemorrhagic fever (Liberia)

United Nations Liberia; Health Life; Plan, et al. (2014)

Accessed 1 July 2014

Keep Safe - Keep Serving. Agenda and General Session IPC Training

Ministry of Health and social Welfare, Liberia (2014)

IPC TRaining Day 2

HIV Prevention Protocols

World Health Organization (2014) C_WHO

Accessed 24 June 2014

Malaria Prophylaxis for Travellers - Guideline for Healthcare Workers

Anti-malaria Campaign Headquarters - Public Health Complex Ministry of Health – Sri Lanka (2019) C2

The document “Malaria Prophylaxis for Travellers: Guideline for Healthcare Workers” (2019) from Sri Lanka provides guidance for healthcare providers on preventing malaria among travelers to endemic areas. It explains that since Sri Lanka was certified malaria-free in 2016, the main risk comes f ... more

Précautions standard pour contrôler les infections à l'hôpital

Organisation Mondiale de la Santé OMS (1998)

Clinical managment
recommended

World Health Organization WHO (2025) C_WHO

Quality clinical care is at the heart of a robust, effective response to outbreaks. Frontline health workers need evidence-based tools and training to provide safe, effective and quality clinical care. The Clinical Management channel includes videos on a range of diseases, such as Ebola, diphther ... more

Уборка и дезинфекция помещений и поверхностей в контексте COVID-19

World Health Organization WHO (2020) C_WHO

Цель настоящего документа - дать указания по очистке и дезинфекции поверхностей окружающей среды в контексте КОВИД-19. Настоящее руководство предназначено для раб� ... more

Rapid guidance on the decommissioning of Ebola care facilities
recommended

World Health Organization WHO (2015) C_WHO

In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isolation centres. The Governments of Guinea, Liberia an ... more

Marburg virus disease (MVD)

Internation Federation of Red Cross (2022) CC2

Hey Facts about the disease